BriovaRx, LLC Sustainability Profile
BriovaRx, LLC, a prominent player in the pharmacy services industry, is headquartered in the United States and operates extensively across various regions. Founded in 2013, the company has established itself as a leader in providing specialised pharmacy solutions, particularly for patients with complex health needs. BriovaRx offers a range of core services, including medication management and clinical support, which are tailored to enhance patient outcomes. What sets BriovaRx apart is its commitment to personalised care and innovative technology, ensuring that patients receive the most effective treatments. With a strong market position, BriovaRx has achieved notable milestones, including recognition for its quality of service and patient satisfaction. The company continues to evolve, focusing on improving healthcare delivery through its unique pharmacy solutions.
DitchCarbon Score
How does BriovaRx, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BriovaRx, LLC's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BriovaRx, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. However, the company is part of a corporate family that includes UnitedHealth Group Incorporated, from which it inherits climate commitments and performance data. BriovaRx's climate initiatives are aligned with those of its parent company, UnitedHealth Group, which has established significant reduction targets and participates in various climate initiatives. These include commitments to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded down to BriovaRx at a corporate family level. While specific reduction targets for BriovaRx are not detailed, the overarching goals set by UnitedHealth Group reflect a commitment to reducing emissions across all scopes, including Scope 1, 2, and 3. This indicates a comprehensive approach to tackling climate change, although specific metrics and achievements for BriovaRx remain unspecified. In summary, while BriovaRx, LLC does not provide its own emissions data or reduction targets, it is integrated into the climate strategies of UnitedHealth Group, which actively pursues sustainability and emissions reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is BriovaRx, LLC's Industry?
How Carbon Intensive is BriovaRx, LLC's Location?
BriovaRx, LLC's Scope 3 Categories Breakdown
BriovaRx, LLC's Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
BriovaRx, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BriovaRx, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
